COFRX | VFINX | COFRX / VFINX | |
Total Expense Ratio | 0.66 | 0.14 | 471% |
Annual Report Gross Expense Ratio | 0.66 | 0.14 | 471% |
Fund Existence | 13 years | 49 years | - |
Gain YTD | 11.331 | 9.815 | 115% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 15.7B | 1.33T | 1% |
Annual Yield % from dividends | 0.54 | 1.09 | 50% |
Returns for 1 year | 8.18 | 16.41 | 50% |
Returns for 3 years | 32.22 | 49.88 | 65% |
Returns for 5 years | 40.95 | 91.33 | 45% |
Returns for 10 years | 84.85 | 207.64 | 41% |
1 Day | |||
---|---|---|---|
STOCK / NAME | Price $ | Chg $ | Chg % |
KNSA | 33.38 | 0.10 | +0.30% |
Kiniksa Pharmaceuticals International plc | |||
EQH | 53.90 | -0.74 | -1.35% |
Equitable Holdings | |||
TCBX | 38.52 | -0.59 | -1.51% |
Third Coast Bancshares | |||
OTLK | 2.34 | -0.09 | -3.70% |
Outlook Therapeutics | |||
CDTG | 0.60 | -0.03 | -4.61% |
CDT Environmental Technology Investment Holdings Limited |